close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis  

What's this?
Dollar184307Point91
Implied share price

Buy Undervalued by 235437.3%

5% margin of safety What's this?

EV / Revenue
Use Average
ABII
Abraxis Bioscience, Inc.
KUN
China Shenghuo Pharmaceutical Hldg, Inc.
Change
GILD
Gilead Sciences, Inc.
Change
SNY
Sanofi SA (ADR)
Change
AGN
Allergan, Inc.
Change
20771.3 8.25 27840.41 6.88 2.11 10.41
All amounts in millions
from last financial year
         
Implied Share Price $184307.91 $46609.13 $351791.82 $540861.84 $690750.10
Market Cap 3,166 1,229,412 169,063 129,109 120,362
Net Debt -203 20 2,276 7,255 15,530
Enterprise Value (EV) 2,963 1,229,432 171,339 72,056 135,992
Revenue 359 44 24,890 34,109 13,062
Balance Sheet          
Total Assets 1,068 58 34,664 97,392 52,529
Total Liabilities 225 56 19,238 41,272 24,198
Shareholders Equity 842 2 15,426 56,120 28,331.1

Where are the EBIT and EBITDA figures?

Certain companies and those in specific industries (for example insurance) do not report financial results at the EBIT or EBITDA line. For these companies where Valuecruncher does not have EBIT or EBITDA numbers we exclude the valuation metrics driven by these figures. Valuecruncher makes our other valuation metrics available for these companies.

To learn more about comparison analysis, please read our guide to comparison analysis

Comments

No comments yet. Login to comment.